ORIC
Price
$4.30
Change
-$0.39 (-8.32%)
Updated
Apr 10, 04:59 PM (EDT)
Capitalization
333.12M
32 days until earnings call
PHVS
Price
$11.71
Change
-$0.59 (-4.80%)
Updated
Apr 10, 04:59 PM (EDT)
Capitalization
670.27M
27 days until earnings call
Ad is loading...

ORIC vs PHVS

Header iconORIC vs PHVS Comparison
Open Charts ORIC vs PHVSBanner chart's image
Oric Pharmaceuticals
Price$4.30
Change-$0.39 (-8.32%)
Volume$15.2K
Capitalization333.12M
Pharvaris
Price$11.71
Change-$0.59 (-4.80%)
Volume$809
Capitalization670.27M
ORIC vs PHVS Comparison Chart
Loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORIC vs. PHVS commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORIC is a Hold and PHVS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (ORIC: $4.69 vs. PHVS: $12.30)
Brand notoriety: ORIC and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORIC: 86% vs. PHVS: 185%
Market capitalization -- ORIC: $333.12M vs. PHVS: $670.27M
ORIC [@Biotechnology] is valued at $333.12M. PHVS’s [@Biotechnology] market capitalization is $670.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORIC’s FA Score shows that 1 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • ORIC’s FA Score: 1 green, 4 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ORIC and PHVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORIC’s TA Score shows that 4 TA indicator(s) are bullish while PHVS’s TA Score has 4 bullish TA indicator(s).

  • ORIC’s TA Score: 4 bullish, 4 bearish.
  • PHVS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ORIC and PHVS are a good buy in the short-term.

Price Growth

ORIC (@Biotechnology) experienced а -18.86% price change this week, while PHVS (@Biotechnology) price change was -17.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.53%. For the same industry, the average monthly price growth was -18.05%, and the average quarterly price growth was -19.90%.

Reported Earning Dates

ORIC is expected to report earnings on Aug 07, 2025.

PHVS is expected to report earnings on Jul 25, 2025.

Industries' Descriptions

@Biotechnology (-7.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($670M) has a higher market cap than ORIC($333M). PHVS YTD gains are higher at: -35.837 vs. ORIC (-41.884). PHVS has higher annual earnings (EBITDA): -127.53M vs. ORIC (-141.79M). PHVS has more cash in the bank: 305M vs. ORIC (256M). PHVS has less debt than ORIC: PHVS (117K) vs ORIC (3.18M). ORIC (0) and PHVS (0) have equivalent revenues.
ORICPHVSORIC / PHVS
Capitalization333M670M50%
EBITDA-141.79M-127.53M111%
Gain YTD-41.884-35.837117%
P/E RatioN/AN/A-
Revenue00-
Total Cash256M305M84%
Total Debt3.18M117K2,721%
TECHNICAL ANALYSIS
Technical Analysis
ORICPHVS
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 25 days ago
85%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJIQX12.59N/A
N/A
PGIM Jennison Global Equity Income R6
JSJCX12.21N/A
N/A
JHancock Small Cap Dynamic Growth C
USGLX54.80N/A
N/A
JHancock U.S. Global Leaders Growth A
FEQIX67.78N/A
N/A
Fidelity Equity-Income
FSMBX13.78N/A
N/A
Tributary Small/Mid Cap Instl Plus

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with KYMR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+10.22%
KYMR - ORIC
50%
Loosely correlated
+13.78%
ATXS - ORIC
46%
Loosely correlated
+8.80%
BPMC - ORIC
45%
Loosely correlated
+3.59%
CCCC - ORIC
45%
Loosely correlated
+7.88%
IDYA - ORIC
43%
Loosely correlated
+8.69%
More

PHVS and

Correlation & Price change

A.I.dvisor tells us that PHVS and ATXS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHVS and ATXS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
+3.97%
ATXS - PHVS
30%
Poorly correlated
+8.80%
MLTX - PHVS
30%
Poorly correlated
+9.40%
MGTX - PHVS
27%
Poorly correlated
+2.39%
AVTE - PHVS
26%
Poorly correlated
-0.40%
IDYA - PHVS
26%
Poorly correlated
+8.69%
More